HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Huot Selected Research

Mianserin

5/2020Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case Series.
1/2018The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Huot Research Topics

Disease

59Parkinson Disease (Parkinson's Disease)
07/2022 - 01/2007
55Dyskinesias (Dyskinesia)
08/2022 - 01/2010
28Psychotic Disorders (Schizoaffective Disorder)
08/2022 - 02/2011
24Parkinsonian Disorders (Parkinsonism)
08/2022 - 01/2010
3Tremor (Tremors)
01/2017 - 10/2013
2Epilepsy (Aura)
07/2020 - 10/2019
2Hallucinations (Hallucination)
05/2020 - 05/2012
1Bullous Pemphigoid (Pemphigoid)
06/2022
1Cognitive Dysfunction
01/2022
1Dementia (Dementias)
01/2022
1Schizophrenia (Dementia Praecox)
09/2018
1Mental Disorders (Mental Disorder)
09/2018
1Tardive Dyskinesia
01/2017
1Movement Disorders (Movement Disorder)
01/2017
1Psychomotor Agitation (Akathisia)
01/2017
1Diabetes Mellitus
03/2015
1Somnambulism (Sleepwalking)
11/2014
1Essential Tremor (Essential Tremors)
11/2014
1Rhabdomyolysis
10/2014
1Arthralgia (Joint Pain)
10/2014

Drug/Important Bio-Agent (IBA)

57Levodopa (L Dopa)FDA LinkGeneric
08/2022 - 01/2007
331- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
08/2022 - 01/2010
19Serotonin (5 Hydroxytryptamine)IBA
04/2022 - 10/2013
13Dopamine (Intropin)FDA LinkGeneric
01/2021 - 01/2008
7Oxidopamine (6 Hydroxydopamine)IBA
08/2022 - 01/2019
6Ondansetron (Zofran)FDA LinkGeneric
04/2022 - 10/2019
6Glutamic Acid (Glutamate)FDA Link
01/2022 - 09/2018
65-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
02/2019 - 10/2011
4Pharmaceutical PreparationsIBA
01/2018 - 06/2013
45-HT1A Serotonin ReceptorIBA
10/2015 - 10/2011
3Granisetron (Kytril)FDA LinkGeneric
04/2022 - 01/2021
3metabotropic glutamate receptor 2IBA
12/2021 - 09/2018
3Monoamine Oxidase (MAO)IBA
12/2020 - 11/2020
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2016 - 01/2015
2Glycine Plasma Membrane Transport ProteinsIBA
08/2022 - 11/2021
2(R)- (N- (3- (4'- fluorophenyl)- 3- (4'- phenylphenoxy)propyl))sarcosineIBA
08/2022 - 11/2021
2Serotonin 5-HT2 Receptor AntagonistsIBA
08/2022 - 01/2018
2Amantadine (Aman)FDA LinkGeneric
01/2022 - 10/2013
2alpha-SynucleinIBA
01/2022 - 03/2011
2Therapeutic UsesIBA
11/2021 - 01/2021
25-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
01/2021 - 03/2020
2Moclobemide (Arima)IBA
11/2020 - 11/2020
2EnzymesIBA
11/2020 - 01/2007
2Mirtazapine (Rexer)FDA LinkGeneric
05/2020 - 03/2017
2MianserinIBA
05/2020 - 01/2018
2Clozapine (Clozaril)FDA LinkGeneric
03/2017 - 05/2012
2Antipsychotic Agents (Antipsychotics)IBA
01/2017 - 05/2012
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2016 - 03/2013
23- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA
02/2015 - 08/2012
2N- methyl- 1- cyclopropyl- 1- piperonylmethylamineIBA
07/2014 - 01/2012
2N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
05/2012 - 05/2011
2N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
05/2012 - 01/2012
1(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA
08/2022
1LY 341495IBA
08/2022
1eglumetadIBA
08/2022
1N- (4- (2- methoxyphenoxy)phenyl)- N- (2,2,2- trifluoroethylsulfonyl)pyrid- 3- ylmethylamineIBA
08/2022
1Dopamine Agonists (Dopamine Agonist)IBA
07/2022
1safinamideIBA
06/2022
1salicylhydroxamic acid (SHAM)IBA
04/2022
1Cholinergic Agents (Cholinergics)IBA
01/2022
1Rivastigmine (Exelon)FDA LinkGeneric
01/2022
1ButyrylcholinesteraseIBA
01/2022
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2021
1Serotonin 5-HT3 Receptor AntagonistsIBA
01/2021
1EscitalopramFDA Link
05/2020
1Clomipramine (Anafranil)FDA LinkGeneric
05/2020
1Amoxapine (Asendin)FDA Link
05/2020
1Antidepressive Agents (Antidepressants)IBA
05/2020
1CitalopramFDA LinkGeneric
05/2020
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
05/2020
1nefazodone (Serzone)FDA LinkGeneric
12/2018
1Trazodone (Trittico)FDA LinkGeneric
01/2018
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2018
1pimavanserinIBA
03/2017
1Aripiprazole (Abilify)FDA Link
01/2017
1Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
01/2016
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2016
1Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA
01/2016
1Adenosine (Adenocard)FDA LinkGeneric
12/2015
13- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA
10/2015
1Pioglitazone (Actos)FDA Link
03/2015
1PPAR gammaIBA
03/2015
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2015
1Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
02/2015
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2015
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2015
1Propranolol (Inderal)FDA LinkGeneric
11/2014
1Rosuvastatin Calcium (Crestor)FDA Link
10/2014
1TC-8831IBA
10/2013
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2013
1Dopamine AntagonistsIBA
06/2013
1CLR151IBA
06/2013
1Dihydroxyphenylalanine (Dopa)IBA
06/2013
1entacapone (Comtan)FDA Link
03/2013
1oxidized low density lipoproteinIBA
03/2013
1N- (6- (2- aminophenylamino)- 6- oxohexyl)- 4- methylbenzamideIBA
02/2013
1Histone Deacetylase InhibitorsIBA
02/2013
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2013
1Illicit Drugs (Recreational Drugs)IBA
05/2012

Therapy/Procedure

16Therapeutics
11/2021 - 01/2010